Michael Gordon, MD
Surgery of the Hand · Sarasota, FLNPI 1376584615
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Endo Pharmaceuticals Inc. at 40.7% of the total. Reporting peaked in 2022 at $8,197 and has fallen 73.0% since, to $2,214 in 2025.
Across 173 payments — averaging $84.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$6K
- Arthrex$5K
- Coastal Medical Technologies LLC$878
- Axogen$582
- Stryker$397
- MVP Orthopedics Inc$286
- plus $1K from 14 others
What the payments were for
- Consulting fees$4,01027%
- Travel & lodging$3,83026%
- Food & beverage$5,29936%
- Education$1,50010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 39 | $5,953 |
| Arthrex | 65 | $5,250 |
| Coastal Medical Technologies LLC | 16 | $878 |
| Axogen | 5 | $582 |
| Stryker | 4 | $397 |
| MVP Orthopedics Inc | 13 | $286 |
| Bioventus LLC | 8 | $216 |
| Medtronic | 2 | $197 |
| Zimmer Biomet | 2 | $186 |
| Johnson & Johnson | 2 | $154 |
| Amgen | 1 | $122 |
| Bridgebio Pharma, Inc. | 1 | $121 |
| Endo USA, Inc. | 6 | $121 |
| Smith+Nephew | 2 | $57 |
| Si-bone, Inc. | 1 | $41 |
| Heraeus Medical, LLC. | 2 | $19 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| ERMI LLC | 1 | $16 |
| Theragen, Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$5,270
- AVANCE NERVE GRAFT$536
- AxoGuard Nerve Connector$432
- AxoGuard Nerve Protector$432
- INTELLIS ADAPTIVESTIM$176
- HOFFMANN$150
- GAMMA$150
- ACCOLADE$139
- Persona$129
- EVENITY$122
- Attruby$121
- TFN ADVANCED$114
How this compares
$14,639 in reported general payments places this provider in the 80th percentile of 60 surgery of the hand providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 219 | $1,107 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $572 |
| Methylprednisolone | 38 | $177 |
| Ibuprofen | 12 | $176 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $170 |
| Gabapentin | 13 | $108 |
| Tramadol Hcl | 35 | $86 |
| Meloxicam | 43 | $75 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Sarasota
- Thomas WrightGainesville$4.1M
- David ShenassaPlantation$109K
- Antonio GayosoSt Petersburg$65K
- Robert GrahamJacksonville Beach$62K
- David FriedmanWeston$42K
- Karan DesaiWinter Garden$39K
- Morad AskariCoral Gables$36K
- Jose BorreroAltamonte Springs$35K
- Francisco Schwartz-FernandesOcala$26K
- David HalpernTampa$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.